Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3


ABSTRACT: We have carried out global gene expression analysis to clarify the interrelationship between 1,25-dihydroxyvitamin D3 and differentiation-driven gene expression patterns in developing human monocyte-derived dendritic cells. Monocytes were treated with 10 nM 1,25-dihydroxyvitamin D3 or vehicle 14 hours after plating for 12 hours or 5 days. Monocytes, differentiating dendritic cells (+/-1,25-dihydroxyvitamin D3 for 12 hours) and immature dendritic cells (+/-1,25-dihydroxyvitamin D3 for 5 days) were harvested. This design allows one to identify genes regulated by differentiation and/or 1,25-dihydroxyvitamin D3 in human monocyte-derived dendritic cells. Experiment Overall Design: Human monocytes were obtained from buffy coats from healthy donors by Ficoll gradient centrifugation followed by immunomagnetic cell separation with anti-CD14-conjugated microbeads. Monocytes were cultured in RPMI-1640 supplemented with 10% FBS, 800 U/ml GM-CSF and 500 U/ml IL-4. Monocytes were treated with 10 nM 1,25-dihydroxyvitamin D3 or vehicle 14 hours after plating for 12 hours or 5 days. Monocytes, differentiating dendritic cells (+/-1,25-dihydroxyvitamin D3 for 12 hours) and immature dendritic cells (+/-1,25-dihydroxyvitamin D3 for 5 days) were harvested. Experiments were performed in biological triplicates representing samples from different donors. 15 samples were processed and hybridized to Human Genome U133 Plus 2.0 Arrays.

ORGANISM(S): Homo sapiens

SUBMITTER: LAJOS SZELES 

PROVIDER: E-GEOD-13762 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype.

Széles Lajos L   Keresztes Gábor G   Töröcsik Dániel D   Balajthy Zoltán Z   Krenács László L   Póliska Szilárd S   Steinmeyer Andreas A   Zuegel Ulrich U   Pruenster Monika M   Rot Antal A   Nagy László L  

Journal of immunology (Baltimore, Md. : 1950) 20090201 4


Activation of vitamin D receptor (VDR) by 1,25-dihydroxyvitamin D(3) (1,25-vitD) reprograms dendritic cells (DC) to become tolerogenic. Previous studies suggested that 1,25-vitD could inhibit the changes brought about by differentiation and maturation of DCs. Underpinning the described phenotypic and functional alterations, there must be 1,25-vitD-coordinated transcriptional events. However, this transcriptional program has not been systematically investigated, particularly not in a developmenta  ...[more]

Similar Datasets

2009-02-15 | GSE13762 | GEO
2010-09-01 | E-GEOD-23073 | biostudies-arrayexpress
2011-06-22 | GSE18993 | GEO
2010-09-01 | GSE23073 | GEO
2013-03-25 | E-GEOD-41184 | biostudies-arrayexpress
2017-01-01 | GSE54765 | GEO
2011-06-22 | E-GEOD-18993 | biostudies-arrayexpress
2017-07-18 | GSE89431 | GEO
2017-09-28 | GSE98093 | GEO
2021-04-06 | GSE157209 | GEO